Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $204B
1-Year Return 26.64%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Quarter Return
+10.91%
1 Year Return
+26.64%
3 Year Return
+125.28%
5 Year Return
+196.8%
10 Year Return
+578.78%
AUM
$140B
AUM Growth
-$127B
Cap. Flow
-$149B
Cap. Flow %
-106.22%
Top 10 Hldgs %
21.76%
Holding
2,666
New
131
Increased
291
Reduced
1,907
Closed
210

Sector Composition

1 Technology 28.11%
2 Healthcare 21.42%
3 Financials 11.42%
4 Industrials 10.68%
5 Consumer Discretionary 10.04%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GFX
2576
DELISTED
Golden Falcon Acquisition Corp.
GFX
-400,440
Closed -$3.99M
MIST icon
2577
Milestone Pharmaceuticals
MIST
$151M
-1,120,336
Closed -$10.3M
NOTV icon
2578
Inotiv
NOTV
$55M
-1,135,070
Closed -$19.1M
NXRT
2579
NexPoint Residential Trust
NXRT
$863M
-4,581
Closed -$212K
RIGL icon
2580
Rigel Pharmaceuticals
RIGL
$720M
-6,867
Closed -$80K
RLMD icon
2581
Relmada Therapeutics
RLMD
$45.5M
-5,937
Closed -$220K
RYI icon
2582
Ryerson Holding
RYI
$739M
-49,292
Closed -$1.27M
RZLT icon
2583
Rezolute
RZLT
$642M
-2,420,000
Closed -$6.67M
SCSC icon
2584
Scansource
SCSC
$978M
-642,752
Closed -$17M
SDGR icon
2585
Schrodinger
SDGR
$1.4B
-9,688
Closed -$242K
SLQT icon
2586
SelectQuote
SLQT
$366M
-23,986
Closed -$18K
THR icon
2587
Thermon Group Holdings
THR
$871M
-186,484
Closed -$2.87M
TMP icon
2588
Tompkins Financial
TMP
$1.02B
-3,010
Closed -$218K
TREE icon
2589
LendingTree
TREE
$970M
-76,124
Closed -$1.82M
TRUE icon
2590
TrueCar
TRUE
$187M
-37,944
Closed -$58K
TYRA icon
2591
Tyra Biosciences
TYRA
$647M
-1,364,036
Closed -$12M
UI icon
2592
Ubiquiti
UI
$34.2B
-33,324
Closed -$9.78M
VERV
2593
DELISTED
Verve Therapeutics
VERV
-7,268
Closed -$250K
VMBS icon
2594
Vanguard Mortgage-Backed Securities ETF
VMBS
$14.7B
-66,906
Closed -$3.02M
VXRT
2595
DELISTED
Vaxart
VXRT
-47,944
Closed -$104K
ZIMV icon
2596
ZimVie
ZIMV
$533M
-2,181,712
Closed -$21.5M
ZVSA
2597
DELISTED
ZyVersa Therapeutics
ZVSA
-600
Closed -$2.1M
ASTH icon
2598
Astrana Health
ASTH
$1.42B
-6,153
Closed -$241K
VSEE
2599
VSee Health, Inc. Common Stock
VSEE
$11M
-118,386
Closed -$1.2M
NBIS
2600
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.5B
$0 ﹤0.01%
15,658
-15,658
-50%